EPID dosimetry for pretreatment quality assurance with two commercial systems
Open Access
- 5 July 2012
- journal article
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 13 (4) , 82-99
Abstract
This study compares the EPID dosimetry algorithms of two commercial systems for pretreatment QA, and analyzes dosimetric measurements made with each system alongside the results obtained with a standard diode array. 126 IMRT fields are examined with both EPID dosimetry systems (EPIDose by Sun Nuclear Corporation, Melbourne FL, and Portal Dosimetry by Varian Medical Systems, Palo Alto CA) and the diode array, MapCHECK (also by Sun Nuclear Corporation). Twenty‐six VMAT arcs of varying modulation complexity are examined with the EPIDose and MapCHECK systems. Optimization and commissioning testing of the EPIDose physics model is detailed. Each EPID IMRT QA system is tested for sensitivity to critical TPS beam model errors. Absolute dose gamma evaluation (3%, 3 mm, 10% threshold, global normalization to the maximum measured dose) yields similar results (within 1%–2%) for all three dosimetry modalities, except in the case of off‐axis breast tangents. For these off‐axis fields, the Portal Dosimetry system does not adequately model EPID response, though a previously‐published correction algorithm improves performance. Both MapCHECK and EPIDose are found to yield good results for VMAT QA, though limitations are discussed. Both the Portal Dosimetry and EPIDose algorithms, though distinctly different, yield similar results for the majority of clinical IMRT cases, in close agreement with a standard diode array. Portal dose image prediction may overlook errors in beam modeling beyond the calculation of the actual fluence, while MapCHECK and EPIDose include verification of the dose calculation algorithm, albeit in simplified phantom conditions (and with limited data density in the case of the MapCHECK detector). Unlike the commercial Portal Dosimetry package, the EPIDose algorithm (when sufficiently optimized) allows accurate analysis of EPID response for off‐axis, asymmetric fields, and for orthogonal VMAT QA. Other forms of QA are necessary to supplement the limitations of the Portal Vision Dosimetry system.PACS numbers: 87.53.Bn, 87.53.Jw, 87.53.Kn, 87.55.Qr, 87.56.Fc, 87.57.uqKeywords
This publication has 45 references indexed in Scilit:
- Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification within vivodosimetryBritish Journal of Radiology, 2010
- A fully electronic intensity-modulated radiation therapy quality assurance (IMRT QA) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systemsRadiology and Oncology, 2010
- The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapyRadiation Oncology, 2008
- Establishing action levels for EPID‐based QA for IMRTJournal of Applied Clinical Medical Physics, 2008
- Use of an amorphous silicon EPID for measuring MLC calibration at varying gantry anglePhysics in Medicine & Biology, 2007
- Off‐axis dose response characteristics of an amorphous silicon electronic portal imaging deviceMedical Physics, 2007
- Amorphous silicon EPID calibration for dosimetric applications: comparison of a method based on Monte Carlo prediction of response with existing techniquesPhysics in Medicine & Biology, 2007
- Evaluation of a 2D diode array for IMRT quality assuranceRadiotherapy and Oncology, 2004
- Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapyMedical Physics, 2003
- Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging deviceMedical Physics, 2001